Yilmaz Mahshid
Fortune : 201 662 $ au 31/05/2026
Fortune : 201 662 $ au 31/05/2026
Dr. Yilmaz Mahshid is a Chief Financial Officer at Egetis Therapeutics AB and an Independent Director at InDex Pharmaceuticals AB. He is on the Board of Directors at Medivir AB, InDex Pharmaceuticals AB and Mahshid Advisors AB. Dr. Mahshid was previously employed as an Investment Manager & Controller by Industrifonden, a Research Analyst by Pareto Securities AB, a Research Analyst by Pareto Öhman AB, and a Research Analyst by E.
Öhman J:or Fondkommission AB. He also served on the board at Flerie AB, Avidicare AB and Venaticus Capital AB. He received his doctorate degree from Karolinska Institutet.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/05/2026 | 306 249 ( 0,07% ) | 201 662 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEDIVIR AB | Directeur/Membre du Conseil | 05/05/2021 |
| EGETIS THERAPEUTICS AB | Directeur Financier/CFO | 01/06/2021 |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/04/2020 |
Mahshid Advisors AB | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Venaticus Capital AB | Directeur/Membre du Conseil | 18/03/2022 |
| EGETIS THERAPEUTICS AB | Directeur Financier/CFO | 01/09/2020 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Comptroller/Controller/Auditor | 30/11/2017 |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2015 |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 18/09/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Finance |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
E. Öhman J:or Fondkommission AB
E. Öhman J:or Fondkommission AB Financial ConglomeratesFinance Operates as a capital management company | Finance |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Avidicare AB
Avidicare AB Medical DistributorsDistribution Services Provides products that reduces airborne bacteria and virus pollution at hospitals. | Distribution Services |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Venaticus Capital AB | |
Mahshid Advisors AB |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national